Finecure Pharma
Ticker > Company >

Finecure Pharma share price

Finecure Pharmaceuticals Ltd.

SECTOR: Pharmaceuticals & Drugs  3258   2   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year7.37%
3 Year12.43%
5 Year22.56%

Profit Growth

1 Year-3.41%
3 Year5.81%
5 Year24.75%

ROE%

1 Year18.33%
3 Year23.78%
5 Year26.75%

ROCE %

1 Year25.74%
3 Year32.17%
5 Year35.34%

Debt/Equity

0.015303114667124

Price to Cash Flow

0

Interest Cover Ratio

122.135090151321

CFO/PAT (5 Yr. Avg.)

0.919835865369272

 Strengths

  • Company has been maintaining healthy ROE of 23.7814255974579% over the past 3 years.
  • Company has been maintaining healthy ROCE of 32.1726156432734% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 122.135090151321.
  • The company has an efficient Cash Conversion Cycle of 24.0961732198134 days.

 Limitations

  • The company has shown a poor profit growth of 5.80770093729559% for the Past 3 years.
  • The company has shown a poor revenue growth of 12.4294078707361% for the Past 3 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 65.13 87.24 98.64 115.46 123.98
Total Expenditure 55.84 72.61 80.22 95.25 103.96
Operating Profit 9.29 14.63 18.41 20.21 20.02
Other Income 0.69 1.04 0.52 1.37 0.61
Interest 0.1 0.1 0.19 0.21 0.16
Depreciation 0.55 0.95 1.06 1.32 1.57
Exceptional Items 0 0 0 -0.39 0
Profit Before Tax 9.33 14.61 17.68 19.67 18.9
Tax 2.09 3.36 4.03 5.86 5.56
Net Profit 7.24 11.26 13.65 13.81 13.34
Adjusted EPS (Rs.) 5.69 8.86 10.74 10.87 10.49

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 1.27 1.27 1.27 12.71 12.71
Total Reserves 27.13 37.91 51.37 53.55 66.88
Borrowings 0.25 0.29 0.93 0.4 0.24
Other N/C liabilities 0.23 0.4 0.73 0.78 1.04
Current liabilities 12.94 18.05 15.42 27.54 25.72
Total Liabilities 41.82 57.92 69.72 94.98 106.6
Assets
Net Block 9.7 10.76 16.46 18.42 35.89
Capital WIP 6.73 9.22 15.65 25.63 16.67
Intangible WIP 0 0 0 0 0
Investments 3.01 4.56 4.12 5.21 5.56
Loans & Advances 0.2 0.22 0.34 0.33 0.31
Other N/C Assets 0 0 0 0.31 0
Current Assets 22.17 33.16 33.15 45.08 48.16
Total Assets 41.82 57.92 69.72 94.98 106.6
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019
Profit from operations 19.67 18.9
Adjustment 1.21 1.6
Changes in Assets & Liabilities -2.41 -3.05
Tax Paid -5.61 -6.08
Operating Cash Flow 12.86 11.37
Investing Cash Flow -14.27 -10.21
Financing Cash Flow -0.55 0.12
Net Cash Flow -1.97 1.28

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Finecure Pharma
X